HORAN Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
HORAN Wealth's BMY Position: Q2 2026 in Review
HORAN Wealth reduced its Bristol-Myers Squibb (BMY) stake by 49% in Q2 2026, selling an estimated $515K and leaving 9,491 shares worth $547K. The position accounts for 0.07% of the portfolio, ranked #139.
HORAN Wealth first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.03M in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- HORAN Wealth held 9,491 shares of Bristol-Myers Squibb worth $547K as of Q2 2026.
- HORAN Wealth sold 8,965 Bristol-Myers Squibb shares in Q2 2026, an estimated $515K.
- Bristol-Myers Squibb made up 0.07% of HORAN Wealth's portfolio in Q2 2026, its #139 holding.
- HORAN Wealth first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
- HORAN Wealth's Bristol-Myers Squibb position peaked at $1.03M in Q1 2026.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on HORAN Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.